Second-Line Lenvatinib in Patients With Recurrent Endometrial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Second-Line Lenvatinib in Patients With Recurrent Endometrial Cancer
Gynecol. Oncol 2020 Jan 16;[EPub Ahead of Print], I Vergote, MA Powell, MG Teneriello, DS Miller, AA Garcia, ON Mikheeva, M Bidzinski, CL Cebotaru, CE Dutcus, M Ren, T Kadowaki, Y Funahashi, RT PensonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.